Literature DB >> 26004155

In vivo and systems biology studies implicate IL-18 as a central mediator in chronic pain.

Kiran Vasudeva1, Yoram Vodovotz2, Nabil Azhar3, Derek Barclay4, Jelena M Janjic5, John A Pollock6.   

Abstract

Inflammation is associated with peripheral neuropathy, however the interplay among cytokines, chemokines, and neurons is still unclear. We hypothesized that this neuroinflammatory interaction can be defined by computational modeling based on the dynamics of protein expression in the sciatic nerve of rats subjected to chronic constriction injury. Using Dynamic Bayesian Network inference, we identified interleukin (IL)-18 as a central node associated with neuropathic pain in this animal model. Immunofluorescence supported a role for inflammasome activation and induction of IL-18 at the site of injury. Combined in vivo and in silico approaches may thus highlight novel targets in peripheral neuropathy.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Chronic constriction injury; Dynamic bayesian network; IL-18; Neuroinflammation; Neuropathic pain

Mesh:

Substances:

Year:  2015        PMID: 26004155      PMCID: PMC4465386          DOI: 10.1016/j.jneuroim.2015.04.012

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  59 in total

1.  Pro- and anti-inflammatory cytokine gene expression in rat sciatic nerve chronic constriction injury model of neuropathic pain.

Authors:  K Okamoto; D P Martin; J D Schmelzer; Y Mitsui; P A Low
Journal:  Exp Neurol       Date:  2001-06       Impact factor: 5.330

Review 2.  Chemokines and cytokines in neuroinflammation leading to neuropathic pain.

Authors:  Norikazu Kiguchi; Yuka Kobayashi; Shiroh Kishioka
Journal:  Curr Opin Pharmacol       Date:  2011-10-21       Impact factor: 5.547

Review 3.  Overview of interleukin-18: more than an interferon-gamma inducing factor.

Authors:  C A Dinarello; D Novick; A J Puren; G Fantuzzi; L Shapiro; H Mühl; D Y Yoon; L L Reznikov; S H Kim; M Rubinstein
Journal:  J Leukoc Biol       Date:  1998-06       Impact factor: 4.962

Review 4.  Wallerian degeneration and peripheral nerve conditions for both axonal regeneration and neuropathic pain induction.

Authors:  Petr Dubový
Journal:  Ann Anat       Date:  2011-03-10       Impact factor: 2.698

5.  Up-regulation of prostaglandin E2 synthesis by interleukin-1beta in human orbital fibroblasts involves coordinate induction of prostaglandin-endoperoxide H synthase-2 and glutathione-dependent prostaglandin E2 synthase expression.

Authors:  Rui Han; Shanli Tsui; Terry J Smith
Journal:  J Biol Chem       Date:  2002-02-14       Impact factor: 5.157

Review 6.  Roles of interleukin-18 in tissue destruction and compensatory reactions.

Authors:  Shin-ichiro Kashiwamura; Haruyasu Ueda; Haruki Okamura
Journal:  J Immunother       Date:  2002 Mar-Apr       Impact factor: 4.456

7.  Relation between interleukin-18 and PGE2 in synovial fluid of osteoarthritis: a potential therapeutic target of cartilage degradation.

Authors:  Hiroyuki Futani; Akira Okayama; Kiyoshi Matsui; Shinichiro Kashiwamura; Takashi Sasaki; Toshikazu Hada; Kenji Nakanishi; Hiroomi Tateishi; Soji Maruo; Haruki Okamura
Journal:  J Immunother       Date:  2002 Mar-Apr       Impact factor: 4.456

8.  The NALP1 inflammasome controls cytokine production and nociception in a rat fracture model of complex regional pain syndrome.

Authors:  Wen-Wu Li; Tian-Zhi Guo; Deyong Liang; Xiaoyou Shi; Tzuping Wei; Wade S Kingery; J David Clark
Journal:  Pain       Date:  2009-10-22       Impact factor: 6.961

Review 9.  Wallerian degeneration: gaining perspective on inflammatory events after peripheral nerve injury.

Authors:  Andrew D Gaudet; Phillip G Popovich; Matt S Ramer
Journal:  J Neuroinflammation       Date:  2011-08-30       Impact factor: 8.322

Review 10.  Cytokines and chemokines at the crossroads of neuroinflammation, neurodegeneration, and neuropathic pain.

Authors:  Geeta Ramesh; Andrew G MacLean; Mario T Philipp
Journal:  Mediators Inflamm       Date:  2013-08-12       Impact factor: 4.711

View more
  12 in total

1.  Low-dose NSAIDs reduce pain via macrophage targeted nanoemulsion delivery to neuroinflammation of the sciatic nerve in rat.

Authors:  Jelena M Janjic; Kiran Vasudeva; Muzamil Saleem; Andrea Stevens; Lu Liu; Sravan Patel; John A Pollock
Journal:  J Neuroimmunol       Date:  2018-02-25       Impact factor: 3.478

Review 2.  Potential Neuroimmune Interaction in Chronic Pain: A Review on Immune Cells in Peripheral and Central Sensitization.

Authors:  Jia-Xuan Yang; Hong-Fei Wang; Ji-Zhun Chen; Han-Yu Li; Ji-Chen Hu; An-An Yu; Jun-Jun Wen; Si-Jia Chen; Wei-Dong Lai; Song Wang; Yan Jin; Jie Yu
Journal:  Front Pain Res (Lausanne)       Date:  2022-07-04

Review 3.  Recent advances in pain management based on nanoparticle technologies.

Authors:  Soraya Babaie; Arezou Taghvimi; Joo-Hyun Hong; Hamed Hamishehkar; Seongpil An; Ki Hyun Kim
Journal:  J Nanobiotechnology       Date:  2022-06-18       Impact factor: 9.429

4.  Effects of placebo administration on immune mechanisms and relationships with central endogenous opioid neurotransmission.

Authors:  Alan Prossin; Alisa Koch; Phillip Campbell; Geoffroy Laumet; Christian S Stohler; Robert Dantzer; Jon-Kar Zubieta
Journal:  Mol Psychiatry       Date:  2021-10-29       Impact factor: 13.437

5.  Cardiac Arrest Disrupts Caspase-1 and Patterns of Inflammatory Mediators Differently in Skin and Muscle Following Localized Tissue Injury in Rats: Insights from Data-Driven Modeling.

Authors:  Ravi Starzl; Dolores Wolfram; Ruben Zamora; Bahiyyah Jefferson; Derek Barclay; Chien Ho; Vijay Gorantla; Gerald Brandacher; Stefan Schneeberger; W P Andrew Lee; Jaime Carbonell; Yoram Vodovotz
Journal:  Front Immunol       Date:  2015-11-20       Impact factor: 7.561

6.  Inflammation Following Traumatic Brain Injury in Humans: Insights from Data-Driven and Mechanistic Models into Survival and Death.

Authors:  Andrew Abboud; Qi Mi; Ava Puccio; David Okonkwo; Marius Buliga; Gregory Constantine; Yoram Vodovotz
Journal:  Front Pharmacol       Date:  2016-09-27       Impact factor: 5.810

7.  Involvement of neutrophils and interleukin-18 in nociception in a mouse model of muscle pain.

Authors:  Shinichirou Yoshida; Yoshihiro Hagiwara; Masahiro Tsuchiya; Masamichi Shinoda; Masashi Koide; Hiroyasu Hatakeyama; Chayanit Chaweewannakorn; Toshihisa Yano; Yasuhito Sogi; Nobuyuki Itaya; Takuya Sekiguchi; Yutaka Yabe; Keiichi Sasaki; Makoto Kanzaki; Eiji Itoi
Journal:  Mol Pain       Date:  2018-01-21       Impact factor: 3.395

8.  Nanomedicine-driven neuropathic pain relief in a rat model is associated with macrophage polarity and mast cell activation.

Authors:  Muzamil Saleem; Brooke Deal; Emily Nehl; Jelena M Janjic; John A Pollock
Journal:  Acta Neuropathol Commun       Date:  2019-07-05       Impact factor: 7.801

9.  Differential Expression of Neuroinflammatory mRNAs in the Rat Sciatic Nerve Following Chronic Constriction Injury and Pain-Relieving Nanoemulsion NSAID Delivery to Infiltrating Macrophages.

Authors:  Andrea M Stevens; Lu Liu; Dylan Bertovich; Jelena M Janjic; John A Pollock
Journal:  Int J Mol Sci       Date:  2019-10-24       Impact factor: 5.923

10.  Targeted cyclooxygenase-2 inhibiting nanomedicine results in pain-relief and differential expression of the RNA transcriptome in the dorsal root ganglia of injured male rats.

Authors:  Andrea M Stevens; Muzamil Saleem; Brooke Deal; Jelena Janjic; John A Pollock
Journal:  Mol Pain       Date:  2020 Jan-Dec       Impact factor: 3.395

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.